SE9601395D0 - New therapeutic treatment 1 - Google Patents

New therapeutic treatment 1

Info

Publication number
SE9601395D0
SE9601395D0 SE9601395A SE9601395A SE9601395D0 SE 9601395 D0 SE9601395 D0 SE 9601395D0 SE 9601395 A SE9601395 A SE 9601395A SE 9601395 A SE9601395 A SE 9601395A SE 9601395 D0 SE9601395 D0 SE 9601395D0
Authority
SE
Sweden
Prior art keywords
therapeutic treatment
new therapeutic
osmolyte
inflammation
infection
Prior art date
Application number
SE9601395A
Other languages
Swedish (sv)
Inventor
Dieter Haeussinger
Original Assignee
Dieter Haeussinger
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Dieter Haeussinger filed Critical Dieter Haeussinger
Priority to SE9601395A priority Critical patent/SE9601395D0/en
Publication of SE9601395D0 publication Critical patent/SE9601395D0/en
Priority to CA002251204A priority patent/CA2251204A1/en
Priority to EP97920677A priority patent/EP0910361A1/en
Priority to PCT/EP1997/001862 priority patent/WO1997038686A1/en
Priority to JP9536746A priority patent/JP2000508331A/en
Priority to AU26971/97A priority patent/AU2697197A/en
Priority to NO984760A priority patent/NO984760L/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/045—Hydroxy compounds, e.g. alcohols; Salts thereof, e.g. alcoholates
    • A61K31/047—Hydroxy compounds, e.g. alcohols; Salts thereof, e.g. alcoholates having two or more hydroxy groups, e.g. sorbitol
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/205—Amine addition salts of organic acids; Inner quaternary ammonium salts, e.g. betaine, carnitine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A61P37/06—Immunosuppressants, e.g. drugs for graft rejection
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/08—Antiallergic agents

Abstract

The present invention is directed to a therapy and suitable compositions involving an effective amount of an osmolyte capable of treating the effects of an infection, an inflammation or an immune dysfunction.
SE9601395A 1996-04-12 1996-04-12 New therapeutic treatment 1 SE9601395D0 (en)

Priority Applications (7)

Application Number Priority Date Filing Date Title
SE9601395A SE9601395D0 (en) 1996-04-12 1996-04-12 New therapeutic treatment 1
CA002251204A CA2251204A1 (en) 1996-04-12 1997-04-14 Use of an osmolyte for treating the effects of an infection, an inflammation or an immune dysfunction
EP97920677A EP0910361A1 (en) 1996-04-12 1997-04-14 Use of an osmolyte for treating the effects of an infection, an inflammation or an immune dysfunction
PCT/EP1997/001862 WO1997038686A1 (en) 1996-04-12 1997-04-14 Use of an osmolyte for treating the effects of an infection, an inflammation or an immune dysfunction
JP9536746A JP2000508331A (en) 1996-04-12 1997-04-14 Use of osmolyte to treat the effects of infection, inflammation or immune disorders
AU26971/97A AU2697197A (en) 1996-04-12 1997-04-14 Use of an osmolyte for treating the effects of an infection, an inflammation or an immune dysfunction
NO984760A NO984760L (en) 1996-04-12 1998-10-12 Use of an osmolyte in the treatment of effects caused by an infection, inflammation or immune dysfunction

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
SE9601395A SE9601395D0 (en) 1996-04-12 1996-04-12 New therapeutic treatment 1

Publications (1)

Publication Number Publication Date
SE9601395D0 true SE9601395D0 (en) 1996-04-12

Family

ID=20402174

Family Applications (1)

Application Number Title Priority Date Filing Date
SE9601395A SE9601395D0 (en) 1996-04-12 1996-04-12 New therapeutic treatment 1

Country Status (7)

Country Link
EP (1) EP0910361A1 (en)
JP (1) JP2000508331A (en)
AU (1) AU2697197A (en)
CA (1) CA2251204A1 (en)
NO (1) NO984760L (en)
SE (1) SE9601395D0 (en)
WO (1) WO1997038686A1 (en)

Families Citing this family (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5998485A (en) * 1997-06-16 1999-12-07 Cedars-Sinai Medical Center Method for modulating immune response with inositol
AUPO821097A0 (en) * 1997-07-25 1997-08-14 Cultor Ltd. A prophylactic
US6926911B1 (en) 1998-12-22 2005-08-09 The University Of North Carolina At Chapel Hill Compounds and methods for the treatment of airway diseases and for the delivery of airway drugs
CA2356637C (en) * 1998-12-22 2011-09-13 The University Of North Carolina At Chapel Hill Compounds and methods for the treatment of airway diseases and for the delivery of airway drugs
US7608640B2 (en) 1999-03-02 2009-10-27 Jallal Messadek Glycine betaine and its use
EP1272201B1 (en) * 2000-04-12 2004-11-24 Bitop Aktiengesellschaft Für Biotechnische Optimierung Use of compatible solutes as substances having free radical scavenging properties
CA2386985A1 (en) * 2000-08-11 2002-02-21 The Lawson Health Research Institute Compositions and methods for inhibiting islet dysfunction and autoimmune disorders
BE1015608A6 (en) 2003-07-15 2005-06-07 Messadek Jallal TREATMENT arteritis.
WO2006050581A2 (en) * 2004-11-10 2006-05-18 Jallal Messadek Betaine as agent against arthropod - or mosquito -borne diseases
BRPI0519606A2 (en) * 2005-01-05 2009-02-25 Abdalla Magd Ahmed Kotb synthesis, production and utility of taurine as a remedy
WO2006086856A1 (en) 2005-02-15 2006-08-24 Messadek, Jallal Combination therapeutic compositions and method of use
US9089568B2 (en) 2005-03-12 2015-07-28 Bitop Ag Method of using compatible solutes containing ectoine and/or hydroxyectoine
MX2007013486A (en) 2005-04-27 2008-03-14 Jallal Messadek Insulins combinations.

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3728444A (en) * 1971-04-28 1973-04-17 Stanley Drug Products Inc Method and compositions for inducing resistance to bacterial infections
WO1991014435A1 (en) * 1990-03-19 1991-10-03 Brigham And Women's Hospital Treatment of osmotic disturbance with organic osmolytes
AU641529B2 (en) * 1990-07-30 1993-09-23 Bloomfield D.A. Zwitterionic compounds and their N-halo derivatives for use in the treatment of clinical conditions
TW282398B (en) * 1993-12-22 1996-08-01 Bristol Myers Squibb Co
US5516798A (en) * 1994-10-11 1996-05-14 North Carolina State University Method for treating diarrhea and a composition therefor

Also Published As

Publication number Publication date
CA2251204A1 (en) 1997-10-23
WO1997038686A1 (en) 1997-10-23
EP0910361A1 (en) 1999-04-28
NO984760D0 (en) 1998-10-12
JP2000508331A (en) 2000-07-04
NO984760L (en) 1998-10-12
AU2697197A (en) 1997-11-07

Similar Documents

Publication Publication Date Title
PT880350E (en) MULTIPLE SCLEROSIS TREATMENT
ATE199643T1 (en) THERAPEUTIC COMBINATION PREPARATION CONTAINING INTERFERON
UA26213C2 (en) MEANS FOR PREVENTION AND TREATMENT OF OSTEOPOROSIS AND PHARMACEUTICAL COMPOSITION AND THEIR BASES
EA200000994A1 (en) APPLICATION OF KABERGOLIN IN TREATING SYNDROME TIRED FOOT
DK0777482T3 (en) Combination preparation for the treatment of immune disorders
SE9601395D0 (en) New therapeutic treatment 1
PL310474A1 (en) Application of rilusole in treating neuro-aids diseases
SE9601396D0 (en) New therapeutic treatment 2
EA200000242A1 (en) FANHINONA APPLICATION FOR THE TREATMENT OF ALZHEIMER'S DISEASE
MXPA01011924A (en) Methods and compositions for modulating immune response and for the treatment of inflammatory disease.
MX9301393A (en) MIGRAINE TREATMENT.
NO962259L (en) Use of dimeticone for the treatment of aphthae and stomatitis
DE69924979D1 (en) TREATMENT OF CHRONIC PAIN
ATE149840T1 (en) TREATMENT OF LIVER CANCER
DE69739482D1 (en) THERAPEUTIC FORMULATIONS CONTAINING SNAKE AND / OR INSECTICIDE TO THE PROPHYLAXIS AND THERAPY OF NEOPLASMS
ES2104223T3 (en) 2 - ((2- (N-ISOBUTYL-N-METHYL) AMINO) -BENCILSULFINIL) BENZMIDAZOLE AS ANTIMICROBIAL AGENT AGAINST HELICOBACTER PYLORI.
DK0572549T3 (en) Treatment of non-small cell lung carcinoma
NO995539L (en) Use of low molecular weight heparins for the prevention and therapy of cerebral edema
NO984198L (en) Procedure for the treatment of aggression
DE3585312D1 (en) APPLICATION OF 1,6-DIMETHYL-4-OXO-1,6,7,8,9A-HEXAHYDRO-4H-PYRIDO (1,2-A) PYRIMIDIN-3-CARBOXAMIDE FOR THE PREVENTION AND TREATMENT OF GASTROINTESTINAL DAMAGE.
CA2103708A1 (en) Treatment of ovarian cancer
EA199700034A2 (en) Solomatov's method for correcting the energetic state in human beings
DE69833317D1 (en) CONAGENINE FOR THE TREATMENT OF ULTRA-TERM COLITIS AND / OR MORBON CROHN
RU94002713A (en) Method for treating children possessing elongated qt interval syndrome
RU94041246A (en) Method of psoriasis treatment